Draft Guidance for the Public and the Food and Drug Administration Staff on Convening Advisory Committee Meetings; Availability

Resumo

The Food and Drug Administration (FDA) is announcing the availability of a draft guidance document entitled "Guidance for the Public and FDA Staff on Convening Advisory Committee Meetings." This draft guidance is intended to provide guidance on when FDA should consider referring a matter to an advisory committee. Elsewhere in this issue of the Federal Register, FDA is announcing the availability of four guidances intended to improve FDA's advisory committee procedures.